Accessibility Menu
 
Idorsia logo

Idorsia

(OTC) IDRSF

Current Price$4.03
Market Cap$1.00B
Since IPO (2017)-78%
5 Year-86%
1 Year+208%
1 Month-22%

Idorsia Financials at a Glance

Market Cap

$1.00B

Revenue (TTM)

$220.58M

Net Income (TTM)

$112.29M

EPS (TTM)

$-0.70

P/E Ratio

-5.75

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$4.03

Volume

20,000

Open

$4.03

Previous Close

$4.03

Daily Range

$4.03 - $4.03

52-Week Range

$1.00 - $5.82

IDRSF News

No articles available.

IDRSF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Idorsia

Industry

Biotechnology

CEO

Srishti Gupta, MD

Headquarters

Allschwil, 4123, CH

IDRSF Financials

Key Financial Metrics (TTM)

Gross Margin

91%

Operating Margin

-53%

Net Income Margin

-51%

Return on Equity

0%

Return on Capital

-38%

Return on Assets

-24%

Earnings Yield

-17.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.00B

Shares Outstanding

248.96M

Volume

20.00K

Short Interest

0.00%

Avg. Volume

2.14K

Financials (TTM)

Gross Profit

$199.67M

Operating Income

$116.38M

EBITDA

$45.49M

Operating Cash Flow

$153.23M

Capital Expenditure

$13.82M

Free Cash Flow

$167.05M

Cash & ST Invst.

$87.24M

Total Debt

$1.27B

Idorsia Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$48.02M

-19.8%

Gross Profit

$38.58M

-3.6%

Gross Margin

80.34%

N/A

Market Cap

$1.00B

N/A

Market Cap/Employee

$912.10K

N/A

Employees

1,100

N/A

Net Income

$78.04M

+7.1%

EBITDA

$52.02M

+30.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.18B

-4.1%

Accounts Receivable

$51.92M

-20.6%

Inventory

$82.05M

+31.0%

Long Term Debt

$1.26B

+20.2%

Short Term Debt

$7.59M

-96.4%

Return on Assets

-24.03%

N/A

Return on Invested Capital

-38.16%

N/A

Free Cash Flow

$46.19M

-293.5%

Operating Cash Flow

$43.33M

-293.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LFTSFLifeTech Scientific Corporation
$0.23+0.00%
PHGUFPharming Group N.V.
$1.51+0.00%
BPMUFBasilea Pharmaceutica AG
$71.00+0.00%
ARRJFArjo AB (publ)
$2.96+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About IDRSF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.